Research Paper Volume 12, Issue 18 pp 18676—18692
Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer
Figure 2. Coordination and co-occurrence of the genomic alterations in patients with pancreatic cancer. (A) Kaplan-Meier plots demonstrated the different overall survival of pancreatic cancer patients with different genomic alterations. P values were generated from Log-rank test. (B) Oncoprint demonstrated the co-occurrence of KRAS, TP53, CDKN2A and SMAD4 alterations in patients with pancreatic cancer derived from TCGA PAAD datasets. Each line represented one patient.